QR Code

Cardio/Kidney Composite End Points: A Post Hoc Analysis of the EMPA‐REG OUTCOME Trial

Background Cardio/kidney composite end points are clinically relevant but rarely analyzed in cardiovascular trials. This post hoc analysis of the EMPA‐REG OUTCOME (Empagliflozin Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients) trial evaluated cardio/kidney composite end point...

Whakaahuatanga katoa

I tiakina i:
Ngā kaituhi matua: João Pedro Ferreira, Bettina Johanna Kraus, Isabella Zwiener, Sabine Lauer, Bernard Zinman, David H. Fitchett, Audrey Koitka‐Weber, Jyothis T. George, Anne Pernille Ofstad, Christoph Wanner, Faiez Zannad
Hōputu: Artigo
Reo:Inglês
I whakaputaina: Wiley 2021-04-01
Rangatū:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Ngā marau:
cardio/kidney composite end points
cardio‐renal
empagliflozin
hazard ratio
win ratio
Urunga tuihono:https://www.ahajournals.org/doi/10.1161/JAHA.120.020053
Ngā Tūtohu: Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!

Ngā tūemi rite